“Global Controlled Release Drug Delivery Market Opportunity and Clinical Trial Outlook 2025” Report Highlights:
-
Development of Controlled Release Drug Delivery Technology
-
Approaches for Controlled Release Drug Delivery
-
Global Controlled Release Drug Clinical Pipeline by Phase, Indication, Drug Class
-
Global Controlled Release Drug Clinical Pipeline: 218 Drugs
-
Marketed Controlled Release Drugs: 118 Drugs
-
Majority Drugs In Phase-II and Phase-III Trials: More Than 80
-
Global Controlled Release Drug Delivery Market Future Outlook
Download Report: https://www.kuickresearch.com/report-global-controlled-release-drug-delivery-market-opportunity–and-clinical-trial-outlook-2025.php
or Contact: neeraj@kuickresearch.com
1. Drug Delivery: An Advancing Trajectory
1.1 Preamble Towards Drug Delivery
1.2 Ideal Mode of Drug Delivery System
2. What is Controlled Release Drug Delivery?
2.1 Novel Drug Delivery Systems
2.2 Preamble to Controlled Release Drug Delivery
3. Development of Controlled Release Drug Delivery Technology
3.1 First Generation
3.2 Second Generation
4. Basics of Controlled Release Drug Delivery
4.1 Prerequisites of Controlled Release Delivery
4.2 Rationale for Controlled Release Drug Delivery
5. Mechanism of Controlled Drug Release
5.1 Diffusion Controlled
5.2 Dissolution Controlled System
5.3 Water Penetration Controlled System
5.4 Erosion Controlled System
5.5 Ion-Exchange Controlled System
6. Cataloging of Controlled Release Drug Delivery
6.1 Classification Based Over Delivery Systems
6.2 Classification Based Over Technicality
6.3 Classification Based Over Routes
7. Approaches for Controlled Release Drug Delivery
7.1 Polymers
7.2 Chronopharmaceutics
7.3 Nanoparticulate Delivery System
8. Global Controlled Release Drug Clinical Pipeline Overview
8.1 Phase
8.2 Country/Region
8.3 Mode of Action
8.4 Drug class
8.5 Indication
9. Application of Controlled Release Drug Delivery
9.1 Diabetes
9.2 Cancer
9.3 Cardiovascular Diseases
9.4 Neurological Disorders
9.5 Infections
10. Drug Designing for Controlled Release Delivery
10.1 Enteral Dosage Formulations
10.1.1 Solid Dosage Forms
10.1.2 Liquid Dosage Forms
10.1.3 Inhalation Dosage Forms
10.2 Parenteral Dosage Forms
10.2.1 Injectable Dosage Forms
10.2.2 Implantable Device
10.3 General Mechanisms of Drug Release
11. Market Inclinations
11.1 Market over Routes of Administration
11.2 Market over Approaches
12. Global Controlled ReleaseDrug Delivery Market Dynamics
12.1 Accelerative Parameters
12.2 Challenges
13. Global Controlled Drug Release Delivery Market Future Outlook
13.1 Ongoing Clinical Trials
13.2 Future Market Opportunities
14. Global Controlled Release Drug Delivery Clinical Trials by Company, Indication and Phase
14.1 Unknown
14.2 Research
14.3 Preclinical
14.4 Clinical
14.5 Phase-I
14.6 Phase-I/II
14.7 Phase-II
14.8 Phase-II/III
14.9 Phase-III
14.10 Preregistration
14.11 Registered
15. Marketed Controlled Release Drug Clinical Insight by Company, Indication and Phase
16. Competitive Landscape
16.1 Allergan
16.2 Amylin Pharmaceuticals
16.3 AstraZeneca
16.4 BioAlliance Pharma
16.5 Biogen
16.6 Collegium Pharmaceutical
16.7 Controlled Therapeutics (Ferring Pharmaceuticals)
16.8 Cosmo Pharmaceuticals
16.9 Egalet
16.10 Elan Corporation
16.11 Encore Therapeutics
16.12 Flamel Technologies
16.13 GlaxoSmithKline
16.14 Heron Therapeutics
16.15 iCeutica
16.16 Mithra Pharmaceuticals
16.17 Neurim Pharmaceuticals
16.18 Novartis
16.19 Orexigen Therapeutics
16.20 Otsuka Pharmaceutical
16.21 Pfizer
16.22 Purdue Pharma
16.23 Syntex Pharmaceuticals International
16.24 Takeda
16.25 Zealand Pharma